Connect with Us
602 Park Point Drive, Suite 225, Golden, CO 80401 – +1 303.495.2073
© 2024 Medical Affairs Professional Society (MAPS). All Rights Reserved Worldwide.
Join us for an exciting webinar, co-organized by KSPM and MAPS, that will highlight the critical role of Medical Affairs in the healthcare industry. Industry experts from Korea and global will discuss the strategic value and tangible impact Medical Affairs professionals make in advancing patient care and driving pharmaceutical innovation.
Don’t miss this opportunity to gain insights and join the conversation on the evolving landscape of Medical Affairs!
Addressing the critical importance of integrating robust scientific understanding into the commercial journey, pinpointing the need for medical affairs to take the helm in defining and communicating the commercial value of healthcare innovations.
From the choice of where to publish to the assessment of impact, every decision holds weight in medical research publication. And yet, the metrics that have been traditionally used to guide these decisions offer only a partial view. The result: a hit-or-miss situation when it comes to reaching the target audience—healthcare professionals (HCPs) and patients. Can a data-driven approach that incorporates both traditional and the newer alternative metrics hold the key to improved publication planning, impact and thereby better patient outcomes?
Tamas is a medical doctor and economist by primary training. He also holds an MSc in Health Economics and in Pharmaceutical Medicine and a PhD. Over the course of 20 years, he has held various leadership positions at Pfizer, where he currently leads the company’s “Accord for a Healthier World” medical program.
In this podcast, we explore the origins of negative opinions of the pharmaceutical industry, and whether a for-profit model can support both innovation and the society’s best interests.
In this podcast, we ask what is the ONE thing a company must implement in their transformation from the 40-slide deck to modern scientific storytelling.
In this podcast, we speak with Jill Donahue, author of the recently published (free!) book, “A Dose of Inspiration: 100 Purpose Stories from Pharma Leaders” about the individual and organizational benefits of discovering your purpose as an employee in the Life Sciences industry.
In this podcast, we talk about new directions in CME — and how to address the continuing need for social learning and perceived authority even as we make information more consumable.
Early involvement of Medical Affairs can be valuable to R&D by providing medical insights from HCPs to influence the TPP, go/no go decision, and optimize the clinical development program. Some biopharma organizations are hiring pipeline MSLs reporting to a Medical Affairs lead within the R&D organization to support clinical trial enrollment efforts and bring the voice of the customer to asset decisions. Defining disease areas of interest is also crucial, involving understanding diseases for which an emerging technology may have an application and determining the existing unmet medical need. Additionally, clarifying the patient journey informs the TPP, clinical feasibility of planned trials, and selection of clinical trial endpoints.
During the webinar, we will discuss considerations for the appropriate structure, resources, and timing to get Medical Affairs involved early enough in the process to optimize clinical development plans informed by medical customer insights. We will also have a dialogue around how early involvement of Medical Affairs can influence which indications should be pursued for a label versus investigator-initiated research.
The more the industry evolves, the more compliance teams need to keep pace with this change. The good news is there are 6 actionable steps you can make to stay ahead of the dynamic pressure.
602 Park Point Drive, Suite 225, Golden, CO 80401 – +1 303.495.2073
© 2024 Medical Affairs Professional Society (MAPS). All Rights Reserved Worldwide.